Curran Terrie 4
4 · Phathom Pharmaceuticals, Inc. · Filed Apr 7, 2023
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Purchase
Common Stock
2023-04-06$7.82/sh+12,919$101,025→ 188,290 total
Holdings
- 2,235.9(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.79 to $7.85. The Reporting Person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.